The Akt of translational control
暂无分享,去创建一个
[1] A. Gingras,et al. eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. , 1999, Annual review of biochemistry.
[2] N. Sonenberg,et al. Atrophy of S6K1−/− skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control , 2005, Nature Cell Biology.
[3] E. Gelfand,et al. Targeted disruption of p70(s6k) defines its role in protein synthesis and rapamycin sensitivity. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[4] A. Fraire,et al. Expression of eukaryotic translation initiation factors 4E and 2α is increased frequently in bronchioloalveolar but not in squamous cell carcinomas of the lung , 2001, Cancer.
[5] J. Testa,et al. Perturbations of the AKT signaling pathway in human cancer , 2005, Oncogene.
[6] S. Gygi,et al. Serum‐stimulated, rapamycin‐sensitive phosphorylation sites in the eukaryotic translation initiation factor 4GI , 2000, The EMBO journal.
[7] M. Schwab,et al. p70S6K Controls Selective mRNA Translation during Oocyte Maturation and Early Embryogenesis inXenopus laevis , 1999, Molecular and Cellular Biology.
[8] RAPT1, a mammalian homolog of yeast Tor, interacts with the FKBP12/rapamycin complex. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[9] M. Torbenson,et al. mTOR and P70 S6 Kinase Expression in Primary Liver Neoplasms , 2004, Clinical Cancer Research.
[10] N. Sonenberg,et al. The Transformation Suppressor Pdcd4 Is a Novel Eukaryotic Translation Initiation Factor 4A Binding Protein That Inhibits Translation , 2003, Molecular and Cellular Biology.
[11] E. Meese,et al. Overexpression of the eukaryotic translation initiation factor 4G (eIF4G‐1) in squamous cell lung carcinoma , 2002, International journal of cancer.
[12] A. De Benedetti,et al. Translational regulation of vascular permeability factor by eukaryotic initiation factor 4E: Implications for tumor angiogenesis , 1996, International journal of cancer.
[13] C. Eng,et al. Germline mutations in PTEN are present in Bannayan-Zonana syndrome , 1997, Nature Genetics.
[14] J. Blenis,et al. Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. , 2002, Genes & development.
[15] M. Pfreundschuh,et al. Translation initiation factor eIF-4gamma is encoded by an amplified gene and induces an immune response in squamous cell lung carcinoma. , 1997, Human molecular genetics.
[16] William R Sellers,et al. The biology and clinical relevance of the PTEN tumor suppressor pathway. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] C. Haipek,et al. Functional significance of S6K overexpression in meningioma progression , 2004, Annals of neurology.
[18] N. Sonenberg,et al. Signaling from Akt to FRAP/TOR Targets both 4E-BP andS6K in Drosophilamelanogaster , 2003, Molecular and Cellular Biology.
[19] S. Gygi,et al. Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism. , 1999, Genes & development.
[20] A. Gingras,et al. Regulation of translation initiation by FRAP/mTOR. , 2001, Genes & development.
[21] A. Gingras,et al. Phosphorylation of eucaryotic translation initiation factor 4B Ser422 is modulated by S6 kinases , 2004, The EMBO journal.
[22] N. Sonenberg,et al. The translation initiation factor eIF-4E binds to a common motif shared by the translation factor eIF-4 gamma and the translational repressors 4E-binding proteins , 1995, Molecular and cellular biology.
[23] José Luis de la Pompa,et al. Negative Regulation of PKB/Akt-Dependent Cell Survival by the Tumor Suppressor PTEN , 1998, Cell.
[24] C. Thompson,et al. Activated Akt promotes increased resting T cell size, CD28‐independent T cell growth, and development of autoimmunity and lymphoma , 2003, European journal of immunology.
[25] B. Edgar,et al. Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins , 2003, Nature Cell Biology.
[26] C. Meschonat,et al. Competitive PCR to detect eIF4E gene amplification in head and neck cancer , 1999, Head & neck.
[27] Roger L. Williams,et al. Phosphoinositide 3-kinases as drug targets in cancer. , 2005, Current opinion in pharmacology.
[28] R. Roth,et al. Evidence of insulin-stimulated phosphorylation and activation of the mammalian target of rapamycin mediated by a protein kinase B signaling pathway. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[29] R. Baserga,et al. IGF-I receptor signalling in transformation and differentiation , 2001, Molecular pathology : MP.
[30] A. Gingras,et al. Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5'-cap function , 1994, Nature.
[31] David M Sabatini,et al. An expanding role for mTOR in cancer. , 2005, Trends in molecular medicine.
[32] J. Eberle,et al. Translation initiation factor eIF‐4A1 mRNA is consistently overexpressed in human melanoma cells in vitro , 1997, International journal of cancer.
[33] T. P. Neufeld,et al. Drosophila PTEN regulates cell growth and proliferation through PI3K-dependent and -independent pathways. , 2000, Developmental biology.
[34] A. Komar,et al. eIF4A: the godfather of the DEAD box helicases. , 2002, Progress in nucleic acid research and molecular biology.
[35] Paul Tempst,et al. RAFT1: A mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs , 1994, Cell.
[36] A. De Benedetti,et al. Progressive amplification and overexpression of the eukaryotic initiation factor 4E gene in different zones of head and neck cancers. , 1999, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.
[37] T. Haystead,et al. Sites That Govern Translational Repression Phosphorylation of Phas-i in Five (s/t)p Multiple Mechanisms Control , 2022 .
[38] R. Burcelin,et al. Hypoinsulinaemia, glucose intolerance and diminished β-cell size in S6K1-deficient mice , 2000, Nature.
[39] Ericka Stricklin-Parker,et al. Ann , 2005 .
[40] M. Wigler,et al. PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer , 1997, Science.
[41] N. Sonenberg,et al. Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' cap , 1990, Nature.
[42] A. De Benedetti,et al. eIF4E expression in tumors: its possible role in progression of malignancies. , 1999, The international journal of biochemistry & cell biology.
[43] S Povey,et al. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. , 1997, Science.
[44] W. Merrick,et al. Assembly of 48S Translation Initiation Complexesfrom Purified Components with mRNAs That Have Some Base Pairingwithin Their 5′ UntranslatedRegions , 2003, Molecular and Cellular Biology.
[45] K. Inoki,et al. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling , 2002, Nature Cell Biology.
[46] B. Woda,et al. Expression of the eukaryotic translation initiation factors 4E and 2alpha in non-Hodgkin's lymphomas. , 1999, The American journal of pathology.
[47] N. Sonenberg,et al. The translational inhibitor 4E-BP is an effector of PI(3)K/Akt signalling and cell growth in Drosophila , 2001, Nature Cell Biology.
[48] Christine C. Hudson,et al. Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin. , 1997, Science.
[49] J. Wands,et al. Overexpression of human insulin receptor substrate 1 induces cellular transformation with activation of mitogen-activated protein kinases , 1996, Molecular and cellular biology.
[50] P. Tsichlis,et al. Tumor induction by an Lck-MyrAkt transgene is delayed by mechanisms controlling the size of the thymus , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[51] N. Sonenberg,et al. The mRNA 5' cap-binding protein, eIF-4E, cooperates with v-myc or E1A in the transformation of primary rodent fibroblasts , 1992, Molecular and cellular biology.
[52] N. Socci,et al. Oncogenic Ras and Akt signaling contribute to glioblastoma formation by differential recruitment of existing mRNAs to polysomes. , 2003, Molecular cell.
[53] E. McConkey,et al. Phosphorylation of Ribosomal Protein S6 , 1981 .
[54] M. James,et al. Phosphatidylinositol 3-Kinase and mTOR Signaling Pathways Regulate RNA Polymerase I Transcription in Response to IGF-1 and Nutrients* , 2004, Journal of Biological Chemistry.
[55] T. Mak,et al. Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease , 2001, Nature Genetics.
[56] N. Sonenberg,et al. Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cells. , 2004, Cancer cell.
[57] C. Kahn,et al. Regulation of Myocardial Contractility and Cell Size by Distinct PI3K-PTEN Signaling Pathways , 2002, Cell.
[58] Stefano Fumagalli,et al. S6K1−/−/S6K2−/− Mice Exhibit Perinatal Lethality and Rapamycin-Sensitive 5′-Terminal Oligopyrimidine mRNA Translation and Reveal a Mitogen-Activated Protein Kinase-Dependent S6 Kinase Pathway , 2004, Molecular and Cellular Biology.
[59] O. Meyuhas,et al. Mitogenic and nutritional signals are transduced into translational efficiency of TOP mRNAs. , 2001, Cold Spring Harbor symposia on quantitative biology.
[60] R. Cardiff,et al. Activation of Akt (Protein Kinase B) in Mammary Epithelium Provides a Critical Cell Survival Signal Required for Tumor Progression , 2001, Molecular and Cellular Biology.
[61] Xinsheng Gao,et al. TSC1 and TSC2 tumor suppressors antagonize insulin signaling in cell growth. , 2001, Genes & development.
[62] N. Sonenberg,et al. mRNAs containing extensive secondary structure in their 5′ non‐coding region translate efficiently in cells overexpressing initiation factor eIF‐4E. , 1992, The EMBO journal.
[63] S. Cook,et al. Phenotypic Spectrum Caused by Transgenic Overexpression of Activated Akt in the Heart* , 2002, The Journal of Biological Chemistry.
[64] N. Sonenberg,et al. Regulation of cap-dependent translation by eIF4E inhibitory proteins , 2005, Nature.
[65] Stefano Fumagalli,et al. Disruption of the p70s6k/p85s6k gene reveals a small mouse phenotype and a new functional S6 kinase , 1998, The EMBO journal.
[66] E. Hafen,et al. Rheb is an essential regulator of S6K in controlling cell growth in Drosophila , 2003, Nature Cell Biology.
[67] F. Amaldi,et al. Transcription inhibitors stimulate translation of 5' TOP mRNAs through activation of S6 kinase and the mTOR/FRAP signalling pathway. , 2000, European journal of biochemistry.
[68] P. Vogt,et al. Oncogenic transformation induced by membrane-targeted Akt2 and Akt3 , 2001, Oncogene.
[69] M. Peterson,et al. Translation Initiation Factor 4E Blocks Endoplasmic Reticulum-mediated Apoptosis* , 2004, Journal of Biological Chemistry.
[70] Tomohiko Maehama,et al. The Tumor Suppressor, PTEN/MMAC1, Dephosphorylates the Lipid Second Messenger, Phosphatidylinositol 3,4,5-Trisphosphate* , 1998, The Journal of Biological Chemistry.
[71] S. Schreiber,et al. Control of p70 S6 kinase by kinase activity of FRAP in vivo , 1995, Nature.
[72] D. Alessi,et al. Mammalian target of rapamycin is a direct target for protein kinase B: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation. , 1999, The Biochemical journal.
[73] R. Pearson,et al. Rapamycin suppresses 5′TOP mRNA translation through inhibition of p70s6k , 1997, The EMBO journal.
[74] J. Eberle,et al. Decreased proliferation of human melanoma cell lines caused by antisense RNA against translation factor eIF-4A1 , 2002, British Journal of Cancer.
[75] C. Meschonat,et al. Pattern of amplification and overexpression of the eukaryotic initiation factor 4E gene in solid tumor. , 1999, The Journal of surgical research.
[76] C. Meschonat,et al. Detection of eIF4E gene amplification in breast cancer by competitive PCR , 1998, Annals of Surgical Oncology.
[77] B. Calabretta,et al. Role of Pescadillo and Upstream Binding Factor in the Proliferation and Differentiation of Murine Myeloid Cells , 2004, Molecular and Cellular Biology.
[78] S. Snyder,et al. RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[79] S. Altuvia,et al. Translation Control of Gene Expression , 1991, Journal of basic and clinical physiology and pharmacology.
[80] Hong Wu,et al. Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[81] M. Peterson,et al. Translation Factor eIF4E Rescues Cells from Myc-dependent Apoptosis by Inhibiting Cytochromec Release* , 2003, The Journal of Biological Chemistry.
[82] P. Kang,et al. Akt/Protein Kinase B Promotes Organ Growth in Transgenic Mice , 2002, Molecular and Cellular Biology.
[83] Cell Growth. , 1962, Science.
[84] J. Blenis,et al. mTOR Controls Cell Cycle Progression through Its Cell Growth Effectors S6K1 and 4E-BP1/Eukaryotic Translation Initiation Factor 4E , 2004, Molecular and Cellular Biology.
[85] J. Blenis,et al. Tuberous Sclerosis Complex Gene Products, Tuberin and Hamartin, Control mTOR Signaling by Acting as a GTPase-Activating Protein Complex toward Rheb , 2003, Current Biology.
[86] N. Sonenberg,et al. Ras mediates translation initiation factor 4E-induced malignant transformation. , 1992, Genes & development.
[87] E. Hafen,et al. Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2. , 2003, Molecular cell.
[88] J. Blenis,et al. An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten+/− mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[89] N. Sonenberg,et al. Suppression of cap-dependent translation in mitosis. , 2001, Genes & development.
[90] C. Sawyers,et al. The phosphatidylinositol 3-Kinase–AKT pathway in human cancer , 2002, Nature Reviews Cancer.
[91] Lewis C Cantley,et al. The phosphoinositide 3-kinase pathway. , 2002, Science.
[92] M. Bjornsti,et al. The tor pathway: a target for cancer therapy , 2004, Nature Reviews Cancer.
[93] I. London,et al. Upregulation of protein synthesis initiation factor eIF-4E is an early event during colon carcinogenesis , 1999, Oncogene.
[94] A. Gingras,et al. 4E-BP3, a New Member of the Eukaryotic Initiation Factor 4E-binding Protein Family* , 1998, The Journal of Biological Chemistry.
[95] Carlos Cordon-Cardo,et al. Pten is essential for embryonic development and tumour suppression , 1998, Nature Genetics.
[96] S. Ferrari,et al. Unmasking a growth factor/oncogene-activated S6 phosphorylation cascade. , 1989, Cellular signalling.
[97] G. G. Stokes. "J." , 1890, The New Yale Book of Quotations.
[98] L. Cantley,et al. Targeting the PI3K-Akt pathway in human cancer: rationale and promise. , 2003, Cancer cell.
[99] N. Sonenberg,et al. eIF4E – from translation to transformation , 2004, Oncogene.
[100] E. Casanova,et al. Genetic inactivation of the transcription factor TIF-IA leads to nucleolar disruption, cell cycle arrest, and p53-mediated apoptosis. , 2005, Molecular cell.
[101] N. Sonenberg,et al. Repression of cap‐dependent translation by 4E‐binding protein 1: competition with p220 for binding to eukaryotic initiation factor‐4E. , 1995, The EMBO journal.
[102] C. Potter,et al. Drosophila Tsc1 Functions with Tsc2 to Antagonize Insulin Signaling in Regulating Cell Growth, Cell Proliferation, and Organ Size , 2001, Cell.
[103] P. Pandolfi,et al. Does the ribosome translate cancer? , 2003, Nature Reviews Cancer.
[104] J. Hauser,et al. Autocrine Transforming Growth Factor α Regulates Cell Adhesion by Multiple Signaling via Specific Phosphorylation Sites of p70S6 Kinase in Colon Cancer Cells* , 2004, Journal of Biological Chemistry.
[105] R. Pearson,et al. mTOR-Dependent Regulation of Ribosomal Gene Transcription Requires S6K1 and Is Mediated by Phosphorylation of the Carboxy-Terminal Activation Domain of the Nucleolar Transcription Factor UBF† , 2003, Molecular and Cellular Biology.
[106] Michael N. Hall,et al. TOR signalling in bugs, brain and brawn , 2003, Nature Reviews Molecular Cell Biology.
[107] N. Sonenberg,et al. PHAS-I as a link between mitogen-activated protein kinase and translation initiation. , 1994, Science.
[108] P. B. Mahajan. Modulation of transcription of rRNA genes by rapamycin. , 1994, International journal of immunopharmacology.
[109] P. Pandolfi,et al. The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis , 2004, Nature Medicine.
[110] Jing Li,et al. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome , 1997, Nature Genetics.
[111] Hua Tang,et al. Transduction of Growth or Mitogenic Signals into Translational Activation of TOP mRNAs Is Fully Reliant on the Phosphatidylinositol 3-Kinase-Mediated Pathway but Requires neither S6K1 nor rpS6 Phosphorylation , 2002, Molecular and Cellular Biology.
[112] C. Sawyers. Will mTOR inhibitors make it as cancer drugs? , 2003, Cancer cell.
[113] M. Clemens,et al. Translational control: the cancer connection. , 1999, The international journal of biochemistry & cell biology.
[114] Goberdhan P Dimri. What has senescence got to do with cancer? , 2005, Cancer cell.
[115] S. Lowe,et al. Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy , 2004, Nature.
[116] I. Grummt,et al. mTOR-dependent activation of the transcription factor TIF-IA links rRNA synthesis to nutrient availability. , 2004, Genes & development.
[117] S. Bodine,et al. Control of Ser2448 Phosphorylation in the Mammalian Target of Rapamycin by Insulin and Skeletal Muscle Load* , 2002, The Journal of Biological Chemistry.
[118] A. Gingras,et al. Cocrystal Structure of the Messenger RNA 5′ Cap-Binding Protein (eIF4E) Bound to 7-methyl-GDP , 1997, Cell.
[119] A. Gingras,et al. 4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt(PKB) signaling pathway. , 1998, Genes & development.
[120] Tian Xu,et al. Akt regulates growth by directly phosphorylating Tsc2 , 2002, Nature Cell Biology.
[121] E. Hafen,et al. Drosophila S6 kinase: a regulator of cell size. , 1999, Science.